Skip to main content

Table 1 Characteristics of patients with newly diagnosed GBM treated with radiation, BEV, and TMZ

From: Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme

Characteristic

Number of patients (n = 23)

Sex

 

  Male

15 (65%)

  Female

8 (35%)

Age (years)

 

  Range

28–76

  Median

55

Surgery

 

  Gross Total Resection

14 (61%)

  Subtotal Resection

5 (22%)

  Biopsy Only

4 (17%)

Number of BEV cycles

 

  Range

1–13

  Median

4

Duration of Follow-Up (months)

 

  Range

10–67

  Median

34

Status at Follow-Up

 

  Alive, without Progression

11 (48%)

  Alive, with Progression of Disease

3 (13%)

  Deceased from Disease

9 (39%)